Hypertrophic (hyper-tro-fic) Cardiomyopathy (cardio-MY-o-pathy) is a disease that impacts possibly as many as 1 in 250 people. It does not discriminate between societal labels of age, race, gender, color, or creed.
Thousands of people are living with undiagnosed Hypertrophic Cardiomyopathy placing them at risk for complications including heart failure and sudden cardiac arrest at any age. HCM has a genetic component and runs in families, however, it is often overlooked in a general examination or confused with many other conditions including an innocent murmur, asthma, anxiety, mitral valve prolapse, and more.
The “Healthy Cardiac Monitoring Act” (HCM Act) aims to ensure the cardiovascular health needs of all children (19 years of age and younger) and those of student-athletes are met by improving the ability of the healthcare providers to identify children and their families at risk for cardiac disorders both genetic and congenital.